98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/apt.70186 | DOI Listing |
J Nat Med
September 2025
Division of Pharmacognosy, Phytochemistry and Narcotics, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-9501, Japan.
We investigated the actual label indications and quality of encapsulated peppermint oil (PO) products marketed as medicinal products for irritable bowel syndrome (IBS) or health food. Quality was multidimensionally evaluated with regard to the original plant source, content of PO and components of safety concern, and formulation. The original plant source was evaluated with reference to the criteria specified in the British and European pharmacopoeias and advanced GC-MS profiling tests, combined with simple discriminant analysis of the major 4 components (menthol, menthone, menthofuran, and isomenthone), which enabled evaluation of the various PO product formulations.
View Article and Find Full Text PDFAliment Pharmacol Ther
July 2025
Department of Anorectal Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China.
Aliment Pharmacol Ther
July 2025
Division of Gastroenterology and Hepatology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Obes Surg
August 2024
Department of Anesthesiology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
Urology
January 2024
Division of Urology, Shaare Zedek Medical Center, Jerusalem, Israel.